Lifeway Foods stock holds steady as kefir maker builds on recent growth

Lifeway Foods stock is trading in the low 20 US dollar range as of early September 2026, with investors watching how the kefir specialist converts recent revenue and margin gains into sustained profitability.

Lifeway Foods stock (ISIN US5318672009) is trading around 22.94 USD as of early September 2026, giving the kefir specialist a market capitalization of about 334.4 million USD according to market data compiled by Yahoo Finance. The stock sits within a 52-week range of 9.93 USD to 28.61 USD, underlining how sharply it has appreciated from last year’s lows.

Revenue growth supports valuation

According to the same Yahoo Finance overview as of April 2, 2025, Lifeway Foods generated trailing twelve-month revenue of 176.78 million USD, with net income attributable to common shareholders of 13.59 million USD. This translates into a profit margin of 7.69 percent and diluted earnings per share of 0.86 USD over that period, indicating that the company has turned solid topline growth into meaningful profitability.

The valuation reflects that improvement: based on the trailing earnings, Yahoo Finance data show a price-to-earnings ratio of about 26.24 as of April 2, 2025. For context, with a market capitalization of roughly 334.4 million USD on revenue of 176.78 million USD, Lifeway trades at about 1.92 times trailing sales, illustrating that investors are willing to pay a premium compared with purely asset-based metrics for its growth and margin profile.

Margins and balance sheet remain key

Beyond headline revenue and earnings, profitability and capital structure metrics are central for investors. Yahoo Finance figures as of April 2, 2025, indicate a return on equity of 22.62 percent and a return on assets of 15.71 percent for Lifeway, underscoring efficient use of capital for a company of its size. The same dataset lists total debt-to-equity at only 0.23 percent and levered free cash flow of 11.8 million USD, suggesting that the balance sheet remains conservative even as the company scales.

The stock’s 52-week range of 9.93 USD to 28.61 USD, combined with the current level around 22.94 USD as of early September 2026, places the share price closer to the upper half of its recent trading corridor. For investors, this means that a large part of the rerating from single-digit prices has already occurred, and future performance will likely hinge on whether Lifeway can maintain or expand its 7.69 percent profit margin while continuing to grow revenue from its core kefir and probiotic lines.

Kefir as a flagship product

Lifeway Foods positions itself as a leader in probiotic cultured dairy products. According to its own investor relations page, the company’s primary product is drinkable kefir, offered in various organic and non-organic sizes and flavors under the Lifeway, GlenOaks Farms and Fresh Made brands. The portfolio also includes European-style soft cheeses, drinkable yogurt and other specialty dairy products aimed at health-conscious consumers, giving the company multiple ways to leverage consumer interest in probiotics.

Stock level and investor perspective

With a share price of around 22.94 USD and a 52-week range stretching from 9.93 USD to 28.61 USD as of early September 2026, Lifeway Foods stock trades well above its lows but below its recent peak, according to Yahoo Finance market data. For investors, the combination of roughly 176.78 million USD in trailing revenue, a 7.69 percent profit margin and a market capitalization around 334.4 million USD provides a concrete framework to weigh the valuation against future growth in the kefir and probiotic category.

Lifeway Foods stock at a glance

• Company: Lifeway Foods Inc.
• ISIN: US5318672009
• Ticker: LWAY
• Trading venue: NASDAQ
• Price (as of April 2, 2025): 22.94 USD
• Market capitalization: 334.4 million USD (as of April 2, 2025)
• Sector / Industry: Consumer Defensive / Packaged Foods
• Index membership: Not part of major headline indices